Product Name | MF | CAS | Details |
---|
Topotecan hydrochloride hydrate | C23H26ClN3O6 | 1044663-62-8 | Details |
Taragarestrant | C25H25Cl2FN2O2 | 2118899-51-5 | Details |
MAX-40279 hydrochloride | C22H24ClFN6OS | 2388506-51-0 | Details |
NOD2 antagonist 1 | C26H26N4O3S | 2411441-54-6 | Details |
KS106 | C18H15BrF3N3O2S | 2408477-50-7 | Details |
TDP1 Inhibitor-2 | C25H14Cl2O5 | 859142-95-3 | Details |
CCR8 antagonist 2 | C23H30ClN3O3S | 2756350-98-6 | Details |
Raltegravir sodium | C20H22FN6NaO5 | 1292804-07-9 | Details |
Tubulin inhibitor 25 | C26H22O8 | 2411697-71-5 | Details |
Lazuvapagon | C27H32N4O3 | 2379889-71-9 | Details |
GGTI-286 hydrochloride | C23H32ClN3O3S | 181141-66-2 | Details |
HIV-1 inhibitor-43 | C24H21ClN2O4S | 2493426-43-8 | Details |
AS1134900 | C25H22N8S | 149760-98-5 | Details |
Dalmelitinib | C22H16FN7O2S | 1637658-98-0 | Details |
Senexin C | C28H27N5O | 2375554-02-0 | Details |
Bromperidol hydrochloride | C21H24BrClFNO2 | 59453-24-6 | Details |
AMPK-IN-3 | C25H33N5O3 | 2417674-27-0 | Details |
SGLT1/2-IN-1 | C25H28O8 | 1673514-65-2 | Details |
KRAS G12C inhibitor 29 | C23H21ClFN5O2 | 847337-63-7 | Details |
Syk Inhibitor II dihydrochloride dihydrate | C14H18ClF3N6O2 | 1965323-05-0 | Details |
IDH1 Inhibitor 5 | C26H34N4O3 | 1940128-37-9 | Details |
KRAS inhibitor-12 | C19H16Cl2FN5OS | 2230874-00-5 | Details |
Y08175 | C23H19FN4O5 | 2223014-57-9 | Details |
SHP504 | C23H15ClN4O4 | 2222280-83-1 | Details |
Xininurad | C15H10Br2FN3O2 | 2365178-28-3 | Details |
CJJ300 | C30H33N3 | 1807631-83-9 | Details |
SW02 | C19H23BrN2O5 | 1010820-68-4 | Details |
JNc-440 | C26H24N4O3 | 1119503-63-7 | Details |
STAT3-IN-13 | C21H20N6O3S | 2248552-86-3 | Details |
Microtubule inhibitor 6 | C24H19FN2O5 | 2416338-64-0 | Details |
Microtubule inhibitor 7 | C25H19FN2O5 | 2416338-65-1 | Details |
Microtubule inhibitor 4 | C25H23FN4O3 | 2411962-64-4 | Details |
ALOX15-IN-2 | C23H29N3O4S | 2764818-23-5 | Details |
EIF2α activator 2 | C21H20F6N2O2 | 1501618-04-7 | Details |
Posenacaftor | C27H27NO5 | 2095064-05-2 | Details |
Estrogen receptor α antagonist 1 | C26H32N2O5 | 2580941-45-1 | Details |
BAY 2476568 | C24H27FN4O4 | 2311901-93-4 | Details |
hGPR91 antagonist 3 | C23H18F4N4O2 | 1314796-31-0 | Details |
UNC9994 hydrochloride | C21H23Cl3N2OS | 2108826-33-9 | Details |
BET bromodomain inhibitor 2 | C23H30N2O5S | 2414195-69-8 | Details |
(Z)-Fluoxastrobin | C21H16ClFN4O5 | 887973-21-9 | Details |
Topoisomerase II inhibitor 4 | C25H25N5O4 | 2560590-49-8 | Details |
KRAS G12C inhibitor 53 | C21H14ClF2N5O2 | 2761968-93-6 | Details |
Nur77 modulator 2 | C26H25NO5 | 2055829-03-1 | Details |
RUSKI-201 dihydrochloride | C20H28ClN3OS | 2320262-09-5 | Details |
MEIS-IN-1 | C24H21F3N2O4 | 2761326-82-1 | Details |
HIV-1 inhibitor-46 | C24H21ClN4OS | 332947-35-0 | Details |
Carbonic anhydrase inhibitor 7 | C23H17N3O5S | 546105-61-7 | Details |
GNE-9278 | C21H27N5O3S | 2315311-83-0 | Details |
BRD4 Inhibitor-23 | C22H19F2N3O4S | 2760307-53-5 | Details |
VII-31 | C23H25NO5S | 2305757-96-2 | Details |
Panamesine | C23H26N2O6 | 139225-22-2 | Details |
Trk-IN-9 | C23H24ClFN6O | 2758623-12-8 | Details |
Rafutrombopag | C25H22N4O5 | 2600513-51-5 | Details |
Vulolisib | C18H19F2N5O3S | 2390105-79-8 | Details |
HIV-1 inhibitor-42 | C22H20N2O5S | 2459929-46-3 | Details |
Anti-melanoma agent 1 | C28H28N2O2 | 2418579-17-4 | Details |
Aha1/Hsp90-IN-1 | C22H17F3N4O2 | 2768265-58-1 | Details |
Lotrafiban | C23H32N4O4 | 171049-14-2 | Details |
KRAS inhibitor-15 | C20H17Cl2FN4OS | 2230873-75-1 | Details |
FLT3/ITD-IN-4 | C25H22N4O5 | 2278278-04-7 | Details |
KRAS inhibitor-16 | C20H16Cl2FN3O2S | 2230873-67-1 | Details |
IHMT-TRK-284 | C25H27N7OS | 2416844-79-4 | Details |
TM-1 | C26H32N2O6 | 921099-13-0 | Details |
KRAS inhibitor-17 | C21H18Cl2FN3O2S | 2230873-65-9 | Details |
CDK7/12-IN-1 | C25H34N8O | 2654075-94-0 | Details |
Carbonic anhydrase inhibitor 11 | C19H15F3N4O3S2 | 2411059-71-5 | Details |
Haloperidol lactate | C24H29ClFNO5 | 53515-91-6 | Details |
ERK1/2 inhibitor 7 | C23H22FN7OS | 2648455-13-2 | Details |
Izilendustat hydrochloride | 1303513-80-5 | Details |
EP4 receptor antagonist 2 | C27H29N3O5 | 1965316-82-8 | Details |
FLT3-IN-12 | C21H23F3N6O | 2499966-67-3 | Details |
GABAA receptor modulator-2 | C22H22FN3O5S | 2413850-54-9 | Details |
Myoferlin inhibitor 1 | C26H28N6O2 | 2366279-99-2 | Details |
HIV-1 inhibitor-34 | C26H27N7O | 2395777-45-2 | Details |
Aurora kinase inhibitor-9 | C19H17Cl2N3O4S | 2419107-09-6 | Details |
TLR7 agonist 4 | C23H34N6O3 | 2413016-42-7 | Details |
FabG1-IN-1 | C14H8Cl2INO3 | 1051177-61-7 | Details |
Aurora A inhibitor 2 | C24H26N6O3 | 2412144-74-0 | Details |
ZY-444 | C26H28N4OS | 1802650-31-2 | Details |
Anticancer agent 32 | C24H21F2N5O | 2222930-76-7 | Details |
Sunobinop | C26H33N3O3 | 1126793-40-5 | Details |
HIV-1 inhibitor-25 | C26H19N5O2 | 2475658-74-1 | Details |
PI3K/mTOR Inhibitor-9 | C23H27N7O2 | 1392421-71-4 | Details |
TYK2-IN-12 | C24H20F2N4O2 | 2244061-66-1 | Details |
IHMT-MST1-58 | C21H22N6O3S | 2414484-25-4 | Details |
BuChE-IN-1 | C23H23FN2O4S | 2669070-40-8 | Details |
OM-1700 | C25H23FN6O2 | 2406276-78-4 | Details |
KRAS inhibitor-18 | C20H15ClF3N3O2S | 2230873-66-0 | Details |
Glucosylceramide synthase-IN-1 | C24H20F4N2O3 | 2601393-20-6 | Details |
Microtubule inhibitor 3 | C26H23FN4O3 | 1236141-96-0 | Details |
FLT3-IN-15 | C22H23ClFN5O2 | 2435562-99-3 | Details |
Aurora Kinases-IN-2 | C22H18ClN5O3 | 2241914-86-1 | Details |
HIV-1 inhibitor-24 | C26H19N5O2 | 2475658-75-2 | Details |
ET-JQ1-OH | C21H21ClN4O2S | 2421153-77-5 | Details |
HIV-1 inhibitor-33 | C25H28N6O | 2395777-43-0 | Details |
GABAA receptor agent 2 TFA | C22H22F3N3O3 | 1781880-44-1 | Details |
VVD-118313 | C19H22Cl2N2O3S | 2875046-27-6 | Details |
TRPC6-IN-3 | C22H22FN5O3 | 2311863-36-0 | Details |
FLT3-IN-11 | C20H25F3N6O | 2499966-50-4 | Details |
Product Total: Product Page: | ||||
76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 |